Initial results of a study examining polatuzumab for first line treatment of DLBCL.
Home / Resource Library / Preliminary analysis of a multicenter study of Pola-R-CHP in untreated Japanese patients with DLBCL (POLASTAR)
Initial results of a study examining polatuzumab for first line treatment of DLBCL.